- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02107326
Randomized Crossover Study to Test the Impact of Using a Software for Smartphones and Tablets in Treating Type 1 Diabetes
Webdia Study: Use of Smartphones to Improve Diabetes Control and Quality of Life in Children With Type 1 Diabetes
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The hypothesis underlying this project, is that most calculations necessary for flexible intensive insulin therapy for type 1 diabetes in children can be performed using software installed on a smartphone or tablet that nowadays is carried by most parents and children. Smartphones and tablets can easily communicate with each other and with a desktop computer via the Internet, thereby permitting the exchange of information such as blood glucose values or types of meals among family members and physicians. Finally, software collecting blood glucose values and merging values obtained on different devices easily permits reviewing these values by the patient and sending them to the physician's office, thereby avoiding consultations during which no blood glucose values are brought by the patient.
We hypothesize that the Webdia software, that will be tested in this randomized crossover study, will increase treatment compliance and therefore will improve diabetes self-management. We believe, the software will facilitate the adaptation of insulin schemes by physicians and therefore will lead to improved HbA1C values. We also think that this software will improve the patient's quality of life.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
GE
-
Geneva, GE, Switzerland, 1211
- University Hospital of Geneva
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 10 - 18 years
- Type 1 diabetes mellitus with positive auto-antibodies against Islet Antigen (IA) 2, insulin, islets, Glutamic Acid Decarboxylase (GAD) 65 or Zink
- Disease duration equal or more than 6 months
- Treatment by subcutaneous insulin: by multiple daily injections of pump therapy
Exclusion Criteria:
- Previous use of Webdia Software
- Absence of hardware necessary to install the Webdia Software
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Webdia Software use
Use of Webdia Software during 3 months by the patient.
Monthly review of blood glucose values by the medical team and automatic adjustment of insulin doses by the team.
|
|
No Intervention: Observation
No use of the software.
No intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Effect of Webdia Software use on HbA1C
Time Frame: 0, 3, 6 and 9 months after inclusion
|
0, 3, 6 and 9 months after inclusion
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Effect of Webdia Software use on quality of life
Time Frame: 0, 3, 6 and 9 months after inclusion
|
Quality of life assessment by the use of the Diabetes Quality of Life for Youths (DQOLY) questionnaire published by Ingersoll et al. 1991.
|
0, 3, 6 and 9 months after inclusion
|
Effect of Webdia Software use on the incidence of hypoglycaemic events
Time Frame: During 2 weeks at the end of the 3-months period of Webdia Software use
|
During 2 weeks at the end of the 3-months period of Webdia Software use
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Philippe Klee, MD-PhD, University Hospital, Geneva
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CER13-272
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Children's National Research InstituteRecruitingProfessional Quality of LifeUnited States
-
Istituto Ortopedico RizzoliUniversity of BolognaRecruitingImprove Quality of LifeItaly
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
-
University of South CarolinaNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingHealth Related Quality of LifeUnited States
-
PharmanexSprim Advanced Life SciencesCompletedHealth-related Quality of LifeUnited States
-
Linkoeping UniversityRecruiting
-
South Valley UniversityActive, not recruitingDeterminants of Health-related Quality of Life for Patients After Renal Lithotripsy: PNL Versus RIRSHealth Related Quality of LifeEgypt
-
Region VästmanlandUnknownHealth Related Quality of Life
Clinical Trials on Webdia Software
-
Hams Hamed AbdelrahmanCompletedAccuracy of Digital Dental ModelEgypt
-
University of California, San FranciscoRecruitingMild Cognitive Impairment | Long-Term Memory DeclineUnited States
-
Cairo UniversityRecruitingSegmentation; BoneEgypt
-
Methinks Software SLNot yet recruitingBrain Ischemia | Stroke, Ischemic | Stroke, Acute | Stroke Hemorrhagic
-
The Methodist Hospital Research InstituteNational Institute on Aging (NIA)CompletedVirtual RealityUnited States
-
Wuhan Union Hospital, ChinaCompleted
-
ProlaioRecruitingHeart Failure | Cardiomyopathy, Hypertrophic | Left Ventricular HypertrophyUnited States
-
Medical Decision Logic, Inc.Unknown
-
Docbot, Inc.RecruitingColorectal Adenoma | Colorectal Adenocarcinoma | Colorectal Polyp | Colorectal SSAUnited States
-
Azienda Sanitaria-Universitaria Integrata di UdineUniversity of UdineEnrolling by invitationMusculoskeletal Pain | Fibromyalgia, PrimaryItaly